Bart A. van den Berg
Fondateur chez VenGen BV
Postes actifs de Bart A. van den Berg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
VenGen BV
 VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Fondateur | 01/07/2001 | - |
| Private Equity Investor | 01/07/2001 | - | |
| Director of Investments | 01/07/2001 | 22/07/2010 | |
Diagnoptics Technologies BV
 Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Directeur Général | 01/06/2004 | - |
Historique de carrière de Bart A. van den Berg
Formation de Bart A. van den Berg
| University of Tilburg | Graduate Degree |
Statistiques
Internationale
| Pays-Bas | 4 |
Opérationnelle
| Founder | 1 |
| Director of Investments | 1 |
| Private Equity Investor | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
VenGen BV
VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Finance |
Diagnoptics Technologies BV
Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Bourse
- Insiders
- Bart A. van den Berg
- Expérience
